Ebenezer’s background is in economics, strategy, and planning. His international experience crosses various industries: investment banking, energy, chemicals, biotechnology, pharmaceuticals, and medical devices.
began his career at Citigroup working in foreign exchange before moving to Royal Dutch Shell. Ebenezer has spent the last 6 years providing economic solutions to pharmaceutical companies, consultancies, and
Ebenezer’s experience within the health sector spans a variety of disciplines including health economics, market access, and strategy portfolio . Ebenezer was a technical lead at OptumInsight
where he led economic model development for Pfizer, Gilead, and Lundbeck. He also successfully delivered a detailed strategy recommendation on the restructuring of a local health economy for NHS England. Ebenezer
has also worked for Deloitte, Parexel, and IMSCG.
Currently, Ebenezer splits his time between health market access, dossier submissions, and technology commercialisation.
Ebenezer has an MPhil
from the University of Cambridge and MIT in Economics (Technology Policy) and a BSc Hons degree in Computer Science and Artificial Intelligence from the University of Edinburgh. He expects to graduate in 2018
from the University of Oxford with a MSc in Biomedical Engineering.
Marcus is a consultant in health economics whose experience covers a wide range of disease areas and interventions. His areas of experience span: oncology, gastroenterology, dermatology, pre term labour and birth, and intrapartum care. Marcus has worked across the full life cycle of health economics consultancy projects from systematic literature reviews, model design and implementation, quality control, through to report writing.
Marcus is an experienced health-economic modeller having built, adapted and conducted quality control assessments on cost-effectiveness and budget-impact models for numerous consultancies and pharmaceutical companies.
As a member of the team at AT, Marcus’s major achievement has been his work on an immunotherapy treatment for melanoma receiving approval in EU5 countries.
Marcus has a BSc Hons degree in Biochemistry from the University of Bristol. He is undertaking an MSc in Economic Evaluation in Healthcare from City, University of London.
Sonny is an interface designer working in health economics. His experience covers a wide range of disease areas and interventions: major depressive disorder, oncology, antifungal, and chronic obstructive pulmonary disease (COPD)
Sonny has experience with graphic design, interface design, and corporate branding. He is experienced with Microsoft excel, Adobe Photoshop, computer-generated imagery (CGI) and web design.
Sonny holds qualifications in 3D animation and computing.
Kenneth is a Consultant in Health Economics. His professional experience spans other areas with experience both in Finance and Financial Technology.
Kenneth’s professional consulting career started with the Corporate and Investment Bank Credit Agricole in Foreign Exchange operations with extensive experience in report writing before moving to Bloomberg, specialising in Fixed Income Analytics.
Currently, Kenneth focusses on statistical analyses, dossier submissions, model adaptation and data extraction in areas of Cardiology, Mental Health and Oncology.
Kenneth holds an M.Sc. from the University of Surrey in International Economics, Finance and Development and a B.Sc. (Hons) degree in Financial Economics with Econometrics from the University of Kent.